Morphine Use in Liver Disease: Safety Considerations

Introduction to Morphine Safety

• Morphine should be used with extreme caution in patients with liver disease as its clearance is decreased and oral bioavailability is significantly increased, requiring substantial dose reductions and extended dosing intervals 1

Pharmacokinetic Changes in Liver Disease

• Morphine's half-life is increased approximately two-fold in patients with liver cirrhosis 2, 3
• Bioavailability increases four-fold in patients with hepatocellular carcinoma compared to healthy individuals 2, 4

Safer Opioid Alternatives for Liver Disease

• Fentanyl is the safest first-line choice for patients with liver failure as its disposition remains largely unaffected by hepatic impairment 1
• Hydromorphone has a relatively stable half-life in patients with liver dysfunction and can be used as an alternative with appropriate dose adjustments 1, 4
• Remifentanil is appropriate for short-term use as it is cleared by ester hydrolysis rather than hepatic metabolism 1

Opioids to Avoid in Liver Disease

• Codeine should be strictly avoided in patients with liver cirrhosis due to unpredictable metabolism and risk of respiratory depression 1, 3
• Tramadol should be avoided as its bioavailability increases two to three-fold in cirrhotic patients 1, 3
• Oxycodone has variable metabolite blood concentrations and greater potency for respiratory depression in patients with liver dysfunction 4

Dosing Recommendations if Morphine Must Be Used

• Start with 50% of the standard dose in patients with liver failure 1
• Consider that morphine may be a major cause of hepatic encephalopathy in patients with liver dysfunction 4

Monitoring and Precautions

• Monitor for signs of opioid accumulation, including excessive sedation, respiratory depression, and worsening encephalopathy 1
• Assess renal function, as many patients with liver failure also have compromised renal function, which can further affect opioid clearance 1